Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (68 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 68 days

Description

This study covers the world outlook for immuno-oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of immuno-oncology as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Aduro BioTech, Amgen, AstraZeneca, Bavarian Nordic, Bristol Myers squibb Company, Celgene Corporation, Celldex Therapeutics, Eli Lilly and Company, EMD Serono, F. Hoffmann-La Roche, Fresenius Kabi, Galena Biopharma, Genentech, Gilead Sciences, Inc., GlaxoSmithKline, ImmunoCellular Therapeutics, Incyte, Johnson & Johnson, Merck & Company, Novartis, Pfizer, Prometheus Laboratories, Regeneron Pharmaceuticals, and Sanofi. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZN1GV2F
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 08 May 2024

It has never been this cheap. We have no record of a lower price.

The 2025-2030 World Outlook for Immuno-Oncology

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

U.S. Cancer Report: December 2015: The newest anticancer treatments for cancer patient

Battaglia contro il cancro con l'immunoterapia: Approcci innovativi per il successo

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Immunotherapy in Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 33-2) (The Clinics: Internal Medicine, Volume 33-2)

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Immuno-Oncology: From Bench to Bedside

Experimental and Applied Immunotherapy

Precision Medicine in Oncology

Immunotherapy of Sarcoma

Brain Tumor Immunotherapy

Immunoterapia nel cancro della testa e del collo

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series)

Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention: 2025 (Advanced Bio-Medical CRISPR Technologies)

Immunotherapy for Gastrointestinal Cancer

Personalized Immunotherapy for Tumor Diseases and Beyond

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Experimental and Applied Immunotherapy

Clinical Applications of Immunomics: 2 (Immunomics Reviews:, 2)

Avances en la inmunoterapia del cáncer: Un estudio exhaustivo: Del banco a la cabecera, historias de triunfo y transformación

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Radioimmunotherapy of Cancer

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

It has never been this cheap. We have no record of a lower price.

The 2025-2030 World Outlook for Immuno-Oncology

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

U.S. Cancer Report: December 2015: The newest anticancer treatments for cancer patient

Battaglia contro il cancro con l'immunoterapia: Approcci innovativi per il successo

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Immunotherapy in Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 33-2) (The Clinics: Internal Medicine, Volume 33-2)

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Immuno-Oncology: From Bench to Bedside

Experimental and Applied Immunotherapy

Precision Medicine in Oncology

Immunotherapy of Sarcoma

Brain Tumor Immunotherapy

Immunoterapia nel cancro della testa e del collo

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series)

Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention: 2025 (Advanced Bio-Medical CRISPR Technologies)

Immunotherapy for Gastrointestinal Cancer

Personalized Immunotherapy for Tumor Diseases and Beyond

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Experimental and Applied Immunotherapy

Clinical Applications of Immunomics: 2 (Immunomics Reviews:, 2)

Avances en la inmunoterapia del cáncer: Un estudio exhaustivo: Del banco a la cabecera, historias de triunfo y transformación

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Radioimmunotherapy of Cancer

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)